. . . . . . . . . . . . "a(SCHEM:Sirolimus) -| p(EGID:2475)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Interestingly, a novel mechanism involving increased translation of HIF-1 mRNA downstream of ErbB2/ ErbB3 dimer has also been described in breast tumor cells. This response was dependent upon the PI-3K pathway and was blocked by the mTOR inhibitor, rapamycin [121]." . . "Selventa" . . . . "2014-07-03T14:32:00.286+02:00"^^ . . .